H19 silencing nucleic acid agents for treating rheumatoid...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/11 (2006.01)

Patent

CA 2675964

The invention relates to the treatment of rheumatoid arthritis, particularly to the use of nucleic acid agents capable of silencing H19 for the treatment of rheumatoid arthritis. The invention provides methods for ameliorating rheumatoid arthritis and symptoms associated therewith, utilizing gene silencing oligonucleotides such as small interfering RNA (siRNA) agents directed to H19.

L'invention porte sur le traitement de l'arthrite rhumatoïde, en particulier sur l'utilisation d'agents nucléotidiques capables d'inhiber H19 dans le but de traiter l'arthrite rhumatoïde. L'invention concerne des procédés qui permettent d'améliorer l'arthrite rhumatoïde et les symptômes associés, au moyen d'oligonucléotides de silençage génique tels que des agents à petits ARN interférants (ARNsi) dirigés contre H19.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

H19 silencing nucleic acid agents for treating rheumatoid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with H19 silencing nucleic acid agents for treating rheumatoid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and H19 silencing nucleic acid agents for treating rheumatoid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1821120

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.